Isabelle De Walsche – Managing Director, Gedeon Richter BeNeLux
Isabelle De Walsche, managing director of Gedeon Richter in Belgium, the Netherlands, and Luxembourg gives an…
Gedeon Richter
Last updated: 13.02.2014
Address: Gyömrői út 19-21, H-1103 Budapest, Hungary,Hungary
Tel: (+36) 1-431-4000
Web: http://www.richter.hu/HU/Pages/home.aspx
Company description
Gedeon Richter Plc. is a Hungarian-controlled Central-Eastern European multinational pharmaceutical company. The parent company and its manufacturing subsidiaries in four countries combine to form the region’s leading pharmaceutical manufacturing group. The Company’s products are available, through its own distribution network, to the inhabitants of some 100 different countries.
Products and services
Our activity includes research, development, manufacture and marketing of human finished drugs, active substances and intermediates.
Interviews
Corina Croitoru – Managing Director of Marketing, Czech Republic and…
With a footprint of over 20 years in the Czech Republic, Gedeon Richter’s affiliate here is a key pillar to the…
Gábor Orbán – CEO, Gedeon Richter
Gábor Orbán, CEO of Gedeon Richter, highlights the recent turnaround of the company’s performance, its…
Andras Gizur – President China & APAC, Gedeon Richter
Andras Gizur, president China & APAC for Gedeon Richter, shares his insights on the current market environment…
Emmanuel Eumont – General Manager, Gedeon Richter France
Emmanuel Eumont, general manager of Gedeon Richter France, discusses the group’s leading position in women’s…
Interview: Corina Croitoru – Country Manager, Gedeon Richter Slovakia
Corina Croitoru of Gedeon Richter Slovakia discusses GR’s footprint in the country, the affiliate’s main growth…
Interview: Giovanna Labbate – Country Manager, Gedeon Richter, Italy
Country Manager Giovanna Labbate talks how Gedeon Richter aims to become the point of reference for women’s…
Interview: Isabelle De Walsche – Managing Director, Gedeon Richter…
Isabelle de Walsche, Managing Director of Gedeon Richter Benelux, provides us with an update on the development of…
Interview: Ksenija Pavletic – CEO PregLem & President Gedeon Richter,…
The president of Gedeon Richter France and CEO of PregLem, a Swiss-based biotech company acquired by Gedeon Richter…
Interview with František Gyürüsi, Managing Director, Gedeon Richter Czech…
Mr. Gyürüsi, Gedeon Richter is a 111-year-old company that is synonymous with the Central and Eastern…
Interview with Andras Gizur, Chief Representative, Gedeon Richter
Since establishing Gedeon Richter’s operations here 16 years ago, you’ve been involved in the full…
Erik Bogsch – Managing Director, Gedeon Richter
Gedeon Richter’s Erik Bogsch discusses the company’s 100th anniversary, it’s growing…
Related
China / Hong Chow Leaves Roche for Big New Role at Merck
In a big career move on a personal level and a sign of China’s continuing significance to global pharma, Hong…
China / Sinopharm Tops Brand Value Rankings; Simcere Splashes $565M on Alzheimer’s Drug; Innovent-Ascentage Tie-Up A Sign of Biotech Deals to Come?
The latest news from the Chinese pharmaceutical industry, including recent deals between domestic pharma giant…
China / Fosun-Kite Yescarta Approval Signals Beginning of CAR-T Era
A historic approval for Fosun-Kite’s CAR-T therapy Yescarta in China looks set to pave the way for further…
China / First CAR-T Approval; AZ & Bayer Take VBP Hit; Lonza Boosts Manufacturing Capacity
The latest news from Chinese pharma, including a historic first approval for Fosun Kite’s CAR-T therapy Yescarta;…
China / New Country President for MSD Amid Changes at HQ & Access Challenges
MSD, which has had a presence in China since 1990, recently appointed Belgian national Anna van Acker to lead its…
China / A New Era of Reform Transforming Regulatory Professionals
Writing in the June edition of DIA’s Global Forum magazine, Harbour BioMed’s Fang Zhou, in conversation…
Hong Kong / HKEX’s Aim to Become World’s #1 Biotech Listing Hub & Challenges for New CEO
With three years having passed since the Hong Kong Stock Exchange (HKEX)’s decision to allow pre-revenue biotechs…
Dun Yang – President & CEO, Anticancer Bioscience
Anticancer Bioscience is an exciting international precision oncology company, applying synthetic lethal approaches…
China / Roche Hoping to Spearhead ‘Created in China’ Push with New Innovation Accelerator
In May 2021 Swiss giant Roche launched the ‘Roche Accelerator’ in Shanghai, a USD 31.1 million investment…
China / BioNTech-Fosun JV; Patent Law Revamp; Hong Kong as a Biotech Listing Hub
The latest news from Chinese pharma, including an overhaul of the country’s patent law; a BioNTech-Fosun tie-up…
China / EpimAb Looks to 2022 IPO & Global Leadership in Bispecific Antibodies
Hot on the heels of a USD 120 million fundraising round, Shanghai-based EpimAb Biotherapeutics is now looking…
Sizhen Wang – CEO & Co-Founder, Genetron Health
Genetron Health is a publicly-traded China-based precision oncology company, covering the “full-cycle” of…
